SCI & TECH
Drug Discovery
Discovering new efficacy of various cannabinoids
Although some measures have been prepared for the approval and importation of CBD-based drugs for patients with rare and intractable diseases in Korea, efforts should be made to prevent national loss and enable stable treatment by replacing imported drugs through the localization of expensive foreign drugs (Epidiolex and Sativex, etc.) supplied by foreign pharmaceutical companies.
Neocannbio is striving to develop new drugs that can overcome intractable diseases and diseases caused by aging through discovery of the efficacy of cannabinoids and production of raw materials.
Novel efficacy and synergistic effect based on cannabinoid derivatives
Existing targeted therapies have secured optimization of selective efficacy, but in most cases, when used alone, the therapeutic effect is lowered due to drug resistance. This is because it promotes resistance in cells or individuals receiving targeted drug therapy, resulting in drug resistance and relapse. In recent years, combination drug prescription and treatment have been used as effective treatments for tumors and infectious diseases.
Therefore, Neocannbio intends to develop a safe synergistic combination drug that can reduce tolerance problems and lower the side effects of drugs through research on the development of combined effects with cannabinoids using anticancer drugs and metabolic disease treatments.